Northern Trust Corp Precigen, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Precigen, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,046,989 shares of PGEN stock, worth $785,241. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,046,989

Previous 1,031,316 1.52%

Holding current value

$785,241

Previous $1.63 Million 38.98%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.91 - $1.88 $14,262 - $29,465	15,673 Added 1.52%	1,046,989 $994,000
Q2 2024 Aug 14, 2024	SELL	$1.27 - $1.75 $64,771 - $89,251	-51,001 Reduced 4.71%	1,031,316 $1.63 Million
Q1 2024 May 14, 2024	SELL	$1.21 - $1.75 $163 - $236	-135 Reduced 0.01%	1,082,317 $1.57 Million
Q4 2023 Feb 13, 2024	SELL	$0.89 - $1.41 $10,681 - $16,922	-12,002 Reduced 1.1%	1,082,452 $1.45 Million
Q3 2023 Nov 13, 2023	SELL	$1.08 - $1.85 $20,311 - $34,792	-18,807 Reduced 1.69%	1,094,454 $1.55 Million
Q2 2023 Aug 11, 2023	SELL	$0.96 - $1.4 $59,779 - $87,178	-62,270 Reduced 5.3%	1,113,261 $1.28 Million
Q1 2023 May 15, 2023	BUY	$0.88 - $2.19 $224,444 - $558,559	255,050 Added 27.71%	1,175,531 $1.25 Million
Q4 2022 Feb 13, 2023	BUY	$1.27 - $2.26 $11,480 - $20,430	9,040 Added 0.99%	920,481 $1.4 Million
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $36,605 - $72,431	-25,961 Reduced 2.77%	911,441 $1.93 Million
Q2 2022 Aug 12, 2022	BUY	$1.15 - $2.53 $19,696 - $43,331	17,127 Added 1.86%	937,402 $1.26 Million
Q1 2022 May 13, 2022	SELL	$1.91 - $3.98 $67,147 - $139,920	-35,156 Reduced 3.68%	920,275 $1.94 Million
Q4 2021 Feb 08, 2022	SELL	$3.53 - $5.5 $43,969 - $68,508	-12,456 Reduced 1.29%	955,431 $3.55 Million
Q3 2021 Nov 15, 2021	SELL	$4.99 - $6.55 $183,537 - $240,915	-36,781 Reduced 3.66%	967,887 $4.83 Million
Q2 2021 Aug 13, 2021	BUY	$6.24 - $8.22 $1.05 Million - $1.38 Million	167,861 Added 20.06%	1,004,668 $6.55 Million
Q1 2021 May 12, 2021	BUY	$6.74 - $10.95 $177,322 - $288,083	26,309 Added 3.25%	836,807 $5.77 Million
Q4 2020 Feb 11, 2021	SELL	$3.75 - $10.56 $6,060 - $17,064	-1,616 Reduced 0.2%	810,498 $8.27 Million
Q3 2020 Nov 16, 2020	BUY	$3.5 - $6.2 $805,199 - $1.43 Million	230,057 Added 39.52%	812,114 $2.84 Million
Q2 2020 Aug 14, 2020	SELL	$2.16 - $5.46 $773,573 - $1.96 Million	-358,136 Reduced 38.09%	582,057 $2.9 Million
Q1 2020 May 14, 2020	BUY	$1.46 - $7.19 $1.37 Million - $6.76 Million	940,193 New	940,193 $3.2 Million

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $156M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Precigen, Inc. Transaction History